KCT0008172招募中未知
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on glucose metabolism compared to AtoRvastatin in atheroscLerotic cardiovascular disease patients with metabolic syndrome: The EZ-PEARL Randomized Trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •Dyslipidemia (LDL-C =100 mg/dL or while taking existing statins)
- •Patient with diagnosis of clinical atherosclerotic cardiovascular disease (acute coronary syndrome, history of myocardial infarction, stable or unstable angina, history of coronary artery reperfusion, stroke or transient stroke, history of peripheral arterial disease or peripheral arterial reperfusion) and no prior diabetes and metabolic syndrome.
排除标准
- •1. Diagnosis of clinical atherosclerotic cardiovascular disease within 1 year
- •2. Acute liver disease or persistent unexplained serum AST or ALT three times the upper limit of normal
- •3. Allergy or hypersensitivity to statins or ezetimibe
- •4. Solid organ transplant recipients
- •5. History of side effects requiring discontinuation of statin administration
- •6. Pregnant women, potentially pregnant or lactating women
- •7. Life expectancy less than 3 years
- •8. If it is judged that follow-up for more than 1 year is not possible
- •9. If the patient is unable to understand or read the consent form
研究者
相似试验
已完成
不适用
Comparison of effects of pitavastatin and atorvastatin on glucose and lipid metabolism in diabateic patients with hyperlipidemiaType 2 diabetic patients with hyperlipidemiaJPRN-UMIN000003554Department of Medicine, Metabolism and Endocrinology Juntendo University School of Medicine30
已完成
不适用
Comparison of Effects of Pitavastatin and Rosuvastatin on Patients With Chronic Heart Failureheart failureJPRN-UMIN000007695Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine30
招募中
不适用
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized TrialDyslipidemiasAtherosclerotic Cardiovascular DiseaseNCT05705804Yonsei University250
已完成
不适用
Effects of low versus high dose of pitavastatin on indices of atherosclerosis in patients with coronary artery diseaseCoronary artery disease with dyslipidemiaJPRN-UMIN000005159agoya City University Graduate School of Medical Sciences40
已完成
3 期
Double-blind follow-on study of Pitavastatin (4 mg) versus Simvastatin (40 mg and 80 mg), with a single-blind extension of treatment, in patients with Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or more risk factors for Coronary Heart DiseaseNL-OMON30052Kowa Research Europe50